Regenxbio (RGNX) Asset Utilization Ratio (2015 - 2025)

Regenxbio's Asset Utilization Ratio history runs 11 years deep, the most recent figure standing at 0.34 for Q4 2025.

• On a quarterly basis, Asset Utilization Ratio rose 101.51% year-over-year to 0.34 in Q4 2025; TTM through Dec 2025 was 0.34, a 101.51% increase from a year earlier, with the FY2025 full-year figure at 0.34, up 112.21% from the prior year.
• Asset Utilization Ratio grew to 0.34 in Q4 2025 per RGNX's latest filing, from 0.29 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.52 in Q3 2022 and bottomed at 0.11 in Q3 2021.
• The 5-year median for Asset Utilization Ratio is 0.18 (2024), against an average of 0.25.
• Biggest YoY gain for Asset Utilization Ratio was 359.18% in 2022; the steepest drop was 73.28% in 2022.
• Year by year, Asset Utilization Ratio stood at 0.49 in 2021, then sank by 73.28% to 0.13 in 2022, then grew by 13.81% to 0.15 in 2023, then climbed by 12.22% to 0.17 in 2024, then surged by 101.51% to 0.34 in 2025.
• Per Business Quant, the three latest RGNX Asset Utilization Ratio figures stand at 0.34 (Q4 2025), 0.29 (Q3 2025), and 0.29 (Q2 2025).